Sol-Gel announces Health Canada approval of EPSOLAY
Source: SeekingAlpha
2025-09-04 07:51:07 ET
More on Sol-Gel Technologies
Read the full article on Seeking Alpha
For further details see:
Sol-Gel announces Health Canada approval of EPSOLAY
Sol-Gel Technologies Ltd.
NASDAQ: SLGL
SLGL Trading
3.18% G/L:
$90 Last:
6,402 Volume:
$88 Open:
SLGL Latest News
December 17, 2025 07:00:00 am
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
November 20, 2025 07:30:00 am
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
SLGL Stock Data
$179,681,649
776,949
16.15%
7
N/A
Biotechnology & Life Sciences
Healthcare
IL
Ness Ziona
